Assura’s (AGR) Overweight Rating Reiterated at Barclays

Assura (LON:AGRGet Rating)‘s stock had its “overweight” rating restated by investment analysts at Barclays in a note issued to investors on Friday, Marketbeat Ratings reports. They currently have a GBX 80 ($1.00) price target on the real estate investment trust’s stock. Barclays‘s price target indicates a potential upside of 22.04% from the stock’s previous close.

AGR has been the topic of several other research reports. Berenberg Bank restated a “hold” rating and issued a GBX 80 ($1.00) target price on shares of Assura in a research note on Wednesday, April 13th. Shore Capital reaffirmed a “buy” rating on shares of Assura in a research note on Friday, April 1st. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of GBX 81 ($1.01).

Shares of AGR stock opened at GBX 65.55 ($0.82) on Friday. The stock’s fifty day simple moving average is GBX 66.25 and its 200 day simple moving average is GBX 67.68. Assura has a one year low of GBX 59.28 ($0.74) and a one year high of GBX 80.60 ($1.01). The firm has a market cap of £1.93 billion and a price-to-earnings ratio of 13.21. The company has a debt-to-equity ratio of 79.83, a current ratio of 4.72 and a quick ratio of 4.72.

About Assura (Get Rating)

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.

See Also

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.